Case Report: Effect of setmelanotide treatment in a young patient with acquired hypothalamic obesity following Escherichia coli sepsis and meningoencephalitis with brain abscess - Scorecard - MDSpire
Advertisement
Case Report: Effect of setmelanotide treatment in a young patient with acquired hypothalamic obesity following Escherichia coli sepsis and meningoencephalitis with brain abscess
Clinical Scorecard: Case Study: Impact of Setmelanotide on a Young Child with Acquired Hypothalamic Obesity After Escherichia coli Sepsis and Meningoencephalitis with Brain Abscess
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Children with acquired hypothalamic obesity, particularly those with inflammatory brain injury, aged 2 years and younger.
Care Setting
Key Highlights
highlight_5
Guideline-Based Recommendations
Diagnosis
Management
Consider pharmacologic activation of MC4R signaling with setmelanotide in selected patients, particularly those with severe symptoms.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Setmelanotide may provide therapeutic benefit in cases of aHO related to inflammatory brain injury, but potential side effects should be monitored.
